Updates

Medica

September 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Medica shot ahead after its pre-close statement said H1 revenues were up 18% year-on-year to £18.6m driven by continued growth in the higher value Nighthawk and Cross Section (i.e. CT, MRI) offerings. The rate of recruitment of radiologists remains strong with a net 33 added in H1 (up 72 over the last 12 months) with 339 now contracted. No information on gross margin was announced.Numis’ eps forecasts are 7.6p this year to end December with 8.4p next year, dropping the prospective PE to 18.6, which remains attractive. Results are due on 12 September. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Spire - 3 directors buy 235,000 shares after fall

Fulham Shore - Signs of a recovery

Medica - Bid at 212p (May 2023)

Medica - Moves into US$1bn US clinical trials market (May 2021)

Medica (November 2020)

Medica Group (August 2020)

Medica - Radiology recruitment jumps in Q2 (May 2018)

Medica (February 2018)

Medica (November 2017)

Medica - Sets up advanced practitioner radiography network alongside radiologist one (May 2017)

Medica - Hot telehealth new issue (April 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X